Yngvild Nuvin Blaker

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Leo Meriranta, Amjad Alkodsi, Annika Pasanen et al. · Blood · 2021 · 121 citations · Full text

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

Massimo Federico, María Dolores Caballero Barrigón, Luigi Marcheselli et al. · The Lancet Haematology · 2018 · 112 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +5

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

Sarah E. Josefsson, Klaus Beiske, Yngvild Nuvin Blaker et al. · Cancer Immunology Research · 2019 · 108 citations · Full text

The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era

Yngvild Nuvin Blaker, Signe Spetalen, Marianne Brodtkorb et al. · British Journal of Haematology · 2016 · 68 citations · Full text

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

Hakan Köksal, Pierre Dillard, Sarah E. Josefsson et al. · Blood Advances · 2019 · 58 citations · Full text